SILVERARC CAPITAL MANAGEMENT, LLC

Q2 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
6/30/2026
Date filed
8/13/2026
Form type
13F-HR
Num holdings
73
Total value ($000)
$962,154
Net value change ($000)
-17,658 (-1.8%)
New positions
20
Sold out positions
22
Turnover %
47.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 55,007 NEW
ORKA 26,174 353.6%
ELVN 24,836 NEW
SGMT 22,631 NEW
URGN 20,888 77.3%
DFTX 18,816 NEW
IMVT 13,564 131.8%
VCYT 12,888 222.7%
ALXO 11,892 NEW
MANE 11,679 NEW
Top Reduces (Value $000, Stocks/ETFs)
KALV -57,902 -100.0%
NUVL -36,361 -100.0%
ASND -28,513 -100.0%
CNTA -18,523 -100.0%
DNTH -16,929 -30.8%
SRRK -16,695 -100.0%
KOD -16,530 -43.7%
CGON -11,259 -100.0%
ABVX -11,087 -32.9%
ALKERMES PLC -10,330 -63.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 63,636 (6.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type